Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dahlberg

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Bioorganic & Medicinal Chemistry Letters|November 29, 2007
Amino acid derivatives as histone deacetylase inhibitorsJed L Hubbs, Hua Zhou, Astrid M Kral, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1)Kevin J Wilson, David J Witter, Jonathan B Grimm, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Christopher L Hamblett, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2)Richard W Heidebrecht, Melissa Chenard, Joshua Close, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimizationSolomon D Kattar, Laura M Surdi, Anna Zabierek, et al.
Communications Biology|April 23, 2021
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillanceSu Chul Jang, Kyriakos D Economides, Raymond J Moniz, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitorsChristopher L Hamblett, Joey L Methot, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Prasun K Chakravarty, Melissa Chenard, et al.
Journal of Medicinal Chemistry|May 26, 2011
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancerJason D Katz, James P Jewell, David J Guerin, et al.
Journal of the American Chemical Society|March 19, 2021
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Bioorganic & Medicinal Chemistry Letters|November 29, 2007
Amino acid derivatives as histone deacetylase inhibitorsJed L Hubbs, Hua Zhou, Astrid M Kral, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2008
Phenylglycine and phenylalanine derivatives as potent and selective HDAC1 inhibitors (SHI-1)Kevin J Wilson, David J Witter, Jonathan B Grimm, et al.
Bioorganic & Medicinal Chemistry Letters|October 28, 2008
SAR profiles of spirocyclic nicotinamide derived selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Christopher L Hamblett, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2009
Exploring the pharmacokinetic properties of phosphorus-containing selective HDAC 1 and 2 inhibitors (SHI-1:2)Richard W Heidebrecht, Melissa Chenard, Joshua Close, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimizationSolomon D Kattar, Laura M Surdi, Anna Zabierek, et al.
Communications Biology|April 23, 2021
ExoSTING, an extracellular vesicle loaded with STING agonists, promotes tumor immune surveillanceSu Chul Jang, Kyriakos D Economides, Raymond J Moniz, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2007
The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitorsChristopher L Hamblett, Joey L Methot, Dawn M Mampreian, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2008
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)Joey L Methot, Prasun K Chakravarty, Melissa Chenard, et al.
Journal of Medicinal Chemistry|May 26, 2011
Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancerJason D Katz, James P Jewell, David J Guerin, et al.
Journal of the American Chemical Society|March 19, 2021
Design of BET Inhibitor Bottlebrush Prodrugs with Superior Efficacy and Devoid of Systemic ToxicitiesFarrukh Vohidov, Jannik N Andersen, Kyriakos D Economides, et al.
Pageof 6